1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. GREENWICH LIFESCIENCES INC
Greenwich LifeSciences Inc XNAS: GLSI

Greenwich LifeSciences Inc Live Stock Price Today, Share Analysis and Chart

about

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane pepti...

Read More
11.39 -0.28 (-2.40%)
30.97% Fall from 52W High
24,643
XNAS Volume

XNAS 28 Aug, 2025 11:40 AM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
0.3 / 100
Momentum Score
Technically Neutral
48.3 / 100
Analyst Price Target
No estimates available

6

S

12

W

4

O

1

T

SWOT Analysis

Greenwich LifeSciences Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..